Nicole Borsje | Investor Relations |
Ming Hsieh | Chief Executive Officer |
Larry Weiss | Chief Medical Officer |
Brandon Perthuis | Chief Commercial Officer |
Paul Kim | Chief Financial Officer |
Kevin DeGeeter | Oppenheimer |
Steven Mah | Piper Sandler |
Katie Tryhane | Crédit Suisse |
Good day, and welcome to the Fulgent Genetics 2Q 2021 Earnings Conference Call. At this time, I would like to turn the conference over to Nicole Borsje with Investor Relations. Please go ahead.
Great. Thanks.